| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.22▲ | 0.22▲ | 0.22▼ | 0.22▼ | 0.22▼ |
| MA10 | 0.22▼ | 0.22▼ | 0.22▼ | 0.23▼ | 0.23▼ |
| MA20 | 0.22▼ | 0.22▼ | 0.22▼ | 0.23▼ | 0.24▼ |
| MA50 | 0.22▼ | 0.22▼ | 0.23▼ | 0.24▼ | 0.63▼ |
| MA100 | 0.22▼ | 0.23▼ | 0.23▼ | 0.26▼ | 2.37▼ |
| MA200 | 0.23▼ | 0.23▼ | 0.22▼ | 0.53▼ | 23.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.000▼ | -0.001▼ | 0.000▼ | 0.036▲ |
| RSI | 43.725▼ | 43.325▼ | 44.344▼ | 45.422▼ | 35.360▼ |
| STOCH | 36.696 | 36.467 | 31.766 | 40.060 | 9.887▼ |
| WILL %R | -56.044 | -64.912 | -68.992 | -68.313 | -94.486▼ |
| CCI | -13.905 | -50.307 | -74.163 | -54.665 | -58.664 |
|
Thursday, August 07, 2025 05:32 AM
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that ...
|
|
Wednesday, August 06, 2025 05:03 AM
Insiders who bought US$213.4k worth of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stock in the last year recovered part of their losses as the stock rose by 10% last week. However, total losses seen ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/08/25 | 0.217 | 0.22 | 0.2141 | 0.2165 | 1,701,660 |
| 15/08/25 | 0.224 | 0.2245 | 0.2081 | 0.2161 | 1,982,470 |
| 14/08/25 | 0.2233 | 0.2279 | 0.2161 | 0.2202 | 2,437,798 |
| 13/08/25 | 0.22 | 0.236 | 0.22 | 0.228 | 5,260,788 |
| 12/08/25 | 0.2241 | 0.2276 | 0.2011 | 0.2207 | 3,390,732 |
| 11/08/25 | 0.2263 | 0.2306 | 0.22 | 0.223 | 4,337,262 |
| 08/08/25 | 0.2299 | 0.2352 | 0.222 | 0.232 | 3,467,576 |
| 07/08/25 | 0.2448 | 0.2497 | 0.2251 | 0.2311 | 38,218,612 |
| 06/08/25 | 0.2423 | 0.243 | 0.225 | 0.2275 | 2,804,939 |
| 05/08/25 | 0.2259 | 0.2469 | 0.2242 | 0.242 | 7,825,188 |
|
|
||||
|
|
||||
|
|